Trial NCT05135845

View at ClinicalTrials.gov 
Org. Study IDs: APHP201152

Last trial update was posted on 2023-02-03

MeSH Interventions

Spartalizumab

MeSH Conditions

Adenocarcinoma

Other Conditions

Gastric Adenocarcinoma Oesophageal Adenocarcinoma

Stopping Reasons

Sponsor decision up DSMB advice due to unfavorable toxicity profile

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID